Pharma Funds News Today

Kotak Healthcare Fund is being launched in the background of healthcare funds returning an average of 25 percent in the last one year. While this sectoral fund category has delivered good returns over long-term periods, timing is key, as pharma funds can see cycles of underperformance.

​

There are 18 pharma-healthcare sector funds, including seven passively managed schemes, which manage assets worth Rs 15,240 crore as on June 30, 2023. Some of these schemes invest in healthcare stocks listed overseas. Are they offering good value?

Toship this trend, and when do you think youre going to know if its working or not? >> well, i think that some of the things that weve started to do are already working. we are making market investments in community violence intervention programs. we set aside an additional $5 million from arma funds that were granted to the city through the american recovery plan argument, through the federal government, and then also were encouraged by the build back better act that is going to set aside $5 bi...

Pharma sector mutual funds have delivered over 60% returns in the last one year. These funds have been enjoying their spot under the sun since the covid-19 crisis struck the globe.

Should you go for pharma funds amid fresh spike in covid cases? Premium On Friday, Axis Mutual Fund launched the Axis Healthcare ETF, which will track the Nifty Healthcare Index. (Mint) Share Via Read Full Story After years of underperformance, the Indian healthcare sector sprang into action post March 2020 as the first wave of covid-19 hit the country. However, from December onwards, the sector went into a healthy correction as investors moved to cyclicals as the economy opened up. The fresh ...

Covid is back. Should you bet on pharma funds to earn better returns ? Synopsis Pharma funds are staging a comeback. After slipping on the return charts in the last six months, pharma funds are topping the charts once again in the last one month. Pharma funds are staging a comeback. After slipping on the return charts in the last six months, pharma funds are topping the charts once again in the last one month. With more than 10% returns in one month, the funds have toppled international sector ...